Climb Bio, Inc. (CLYM) Q3 2024 Earnings
CLYM·Reported November 12, 2024·Before market open
Diluted EPS came in at $-0.13.
Diluted EPS
$-0.13
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about Climb Bio, Inc.'s Q3 2024 earnings report.
Climb Bio, Inc. (CLYM) reported Q3 2024 earnings on November 12, 2024 before market open.
Climb Bio, Inc. reported diluted EPS of $-0.13 for Q3 2024.
You can read the 10-Q periodic report (0000950170-24-125294) directly on SEC EDGAR. The filing index links above go to sec.gov.